Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
British Journal of Anaesthesia
|
June 4, 2021
Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery
Ke Peng, Yue-Ping Shen, Yao-Yu Ying, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients
William S Weintraub, William E Boden, Zugui Zhang, et al.
The Lancet. Public Health
|
December 3, 2022
The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study
Xue Cao, Zhenping Zhao, Yuting Kang, et al.
Journal of the American College of Cardiology
|
January 10, 2015
Cost-effectiveness of revascularization strategies: the ASCERT study
Zugui Zhang, Paul Kolm, Maria V Grau-Sepulveda, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina
Zugui Zhang, Paul Kolm, William E Boden, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Journal of the American Heart Association
|
May 6, 2021
Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data
Brandon K Bellows, Yiyi Zhang, Zugui Zhang, et al.
JAMA Network Open
|
February 14, 2022
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Journal of the American College of Cardiology
|
April 23, 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events
Adam P Bress, Tom Greene, Catherine G Derington, et al.
The New England Journal of Medicine
|
August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
Adam P Bress, Brandon K Bellows, Jordan B King, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
British Journal of Anaesthesia
|
June 4, 2021
Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery
Ke Peng, Yue-Ping Shen, Yao-Yu Ying, et al.
Circulation. Cardiovascular Quality and Outcomes
|
December 25, 2009
Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients
William S Weintraub, William E Boden, Zugui Zhang, et al.
The Lancet. Public Health
|
December 3, 2022
The burden of cardiovascular disease attributable to high systolic blood pressure across China, 2005-18: a population-based study
Xue Cao, Zhenping Zhao, Yuting Kang, et al.
Journal of the American College of Cardiology
|
January 10, 2015
Cost-effectiveness of revascularization strategies: the ASCERT study
Zugui Zhang, Paul Kolm, Maria V Grau-Sepulveda, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina
Zugui Zhang, Paul Kolm, William E Boden, et al.
Journal of the American Heart Association
|
December 29, 2023
Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Journal of the American Heart Association
|
May 6, 2021
Estimating Systolic Blood Pressure Intervention Trial Participant Posttrial Survival Using Pooled Epidemiologic Cohort Data
Brandon K Bellows, Yiyi Zhang, Zugui Zhang, et al.
JAMA Network Open
|
February 14, 2022
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
William S Weintraub, Deepak L Bhatt, Zugui Zhang, et al.
Journal of the American College of Cardiology
|
April 23, 2021
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events
Adam P Bress, Tom Greene, Catherine G Derington, et al.
The New England Journal of Medicine
|
August 24, 2017
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
Adam P Bress, Brandon K Bellows, Jordan B King, et al.
Page
of 8